Leaflet: information for the user
Lisinopril Teva 20 mg tablets EFG
Read this leaflet carefully before you start taking this medicine,because it contains important information for you. ?Keep this leaflet, as you may need to read it again. ?If you have any questions, consult your doctor or pharmacist. ?This medicine has been prescribed for you only, and you must not give it to others, even if they have the same symptoms as you, as it may harm them. ?If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. |
1. What Lisinopril Teva is and what it is used for
2. What you need to know before you start taking Lisinopril Teva
3. How to take Lisinopril Teva
4. Possible side effects
5. Storage of Lisinopril Teva
6. Contents of the pack and additional information
Lisinopril is an antihypertensive that belongs to the group of medications known as angiotensin-converting enzyme inhibitors (ACE inhibitors).
Lisinopril Teva is indicated for:
Lisinopril is recommended for use in children (over 6 years old) only for the treatment of elevated blood pressure (hypertension).
Lisinopril should not be used in children with severe renal insufficiency.
Do not take Lisinopril Teva
Warnings and precautions
Consult your doctor or pharmacist before starting to take Lisinopril:
Your doctor may monitor your kidney function, blood pressure, and electrolyte levels in your blood (such as potassium) at regular intervals. See also the information under the heading "Do not take Lisinopril Teva".
You must inform your doctor if you think you are (or may become) pregnant. Lisinopril is not recommended in the first months of pregnancy, and should not be taken if you are more than 3 months pregnant, as it may cause serious harm to the baby if used in this period (see section 2: Pregnancy and breastfeeding).
Inform your doctor or dentist that you are taking Lisinopril Teva tablets if you are to undergo an operation that requires anesthesia (including dental treatments).
If you develop persistent dry cough after starting treatment with Lisinopril Teva, consult your doctor.
Pediatric population
Lisinopril has been studied in children. For more information, consult your doctor. Lisinopril Teva is not recommended for children under 6 years or children with severe kidney problems.
Taking Lisinopril Teva with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Consult your doctor if you are taking any of the following medications:
Your doctor may need to modify your dose and/or take other precautions:
Consult your doctor before taking Lisinopril Teva with any of the following medications, as they may reduce the effectiveness of Lisinopril Teva:
Consult your doctor before taking Lisinopril Teva with any of the following medications, as they may increase the risk of developing leukopenia (a reduction in the number of white blood cells):
The following medications may increase the risk of angioedema (signs of angioedema include facial swelling, lips, tongue, and/or throat with difficulty swallowing or breathing):
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
You must inform your doctor if you think you are (or may become) pregnant. Normally, your doctor will advise you to stop taking lisinopril before becoming pregnant or as soon as you know you are pregnant and recommend that you take another medication instead of lisinopril. Lisinopril is not recommended in the first months of pregnancy, and should not be taken if you are more than 3 months pregnant, as it may cause serious harm to the baby if used after the third month of pregnancy.
Breastfeeding
Inform your doctor if you are breastfeeding or plan to start breastfeeding. Lisinopril is not recommended for breastfeeding mothers, and your doctor may choose another treatment for you if you wish to breastfeed your baby, especially if it is a newborn or premature.
Driving and operating machines
It is unlikely that Lisinopril Teva tablets will affect your ability to drive vehicles or operate machines; however, if you experience dizziness or fatigue, avoid tasks that require special attention until you know how you tolerate the medication.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The tablets should be swallowed preferably with a glass of water approximately at the same time of day. Lisinopril Teva can be taken with or without food.
The recommended dose is:
Adults and elderly patients
The treatment usually starts with 10 mg once a day. Some patients, such as those with kidney problems, may start with a lower dose. Then, the dose will be increased gradually every 2-4 weeks until blood pressure is controlled.
The usual long-term dose is 20 mg once a day.
The treatment usually starts in the hospital with a dose of 2.5 mg once a day. Then, the dose will be increased gradually until symptoms are controlled.
The usual long-term dose is 5-35 mg once a day. The dose of any diuretic being taken may be reduced before starting treatment with Lisinopril Teva.
The usual dose is 5 mg on the first and second day, then 10 mg once a day, which is usually continued for 6 weeks. Patients with low blood pressure (hypotension) are usually given a lower dose of 2.5 mg with a maintenance dose of 5 mg, with temporary reductions to 2.5 mg if necessary. If low blood pressure persists, your doctor may discontinue treatment with Lisinopril Teva.
The treatment usually starts with a dose of 10 mg once a day. Then, the dose will be adjusted gradually according to needs. The usual long-term dose is 10-20 mg once a day.
Some Afro-Caribbean patients may require higher doses of Lisinopril Teva to achieve adequate symptom control.
Children under 6 years
Lisinopril is not recommended for use in children.
Children and adolescents aged 6 to 16 years
The dose depends on your weight. The usual initial dose is between 2.5 mg and 5 mg once a day, which may be increased up to a maximum of 20 mg to 40 mg once a day. Patients with kidney problems should take lower doses. Your doctor will decide on the correct dose for you.
If you take more Lisinopril Teva than you should
If you (or someone) ingest a large amount of tablets or think a child has swallowed some tablets, contact the nearest hospital or your doctor immediately. An overdose can cause severe low blood pressure, arrhythmias, dizziness, anxiety, cough, electrolyte imbalances, kidney insufficiency, whose symptoms are drowsiness, nausea, vomiting, difficulty breathing, and fainting. Please take this leaflet, the remaining tablets, and the packaging to the hospital or your doctor so they know how many tablets you have taken.
In case of overdose or accidental ingestion, consult the Toxicology Information Service. Phone 91 562 04 20.
If you forget to take Lisinopril Teva
If you forget to take a tablet, take it as soon as you remember, unless it is almost time for your next tablet.
Do not take a double dose to make up for missed doses.
If you discontinue treatment with Lisinopril Teva
Do not discontinue treatment without consulting your doctor first, even if you feel better.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you experience any of the following reactions, stop taking Lisinopril Teva and consult your doctor immediately.
If you take Lisinopril Teva for the first time, you may feel dizzy or disoriented for a short period of time. This is unlikely to occur if you take the tablets regularly. Consult your doctor if you are concerned.
The following side effects have been described according to the following frequency categories:
Frequent(may affect up to 1 in 10 people):
Infrequent(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Very rare(may affect up to 1 in 10,000 people):
Unknown(cannot be estimated from available data):
A high incidence of angioedema (facial or body swelling) has been reported in the Afro-Caribbean population.
While taking Lisinopril Teva, changes in blood and urine tests may occur. Therefore, your treatment should be regularly monitored by performing blood and urine tests.
Reporting of side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use, Website:www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not store at a temperature above 25°C. Store in the original packaging. Do not transfer to another container.
Do not use Lisinopril Teva after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash.Deposit the containers and medicines you no longer need at the SIGRE point of the pharmacy.If in doubt, please ask your pharmacist how to dispose of the containers and medicines you no longer need. By doing so, you will help protect the environment.
Composition of Lisinopril Teva 20mg tablets
- The active substance is lisinopril (as dihydrate)
Each tablet contains 20mg of lisinopril in the form of lisinopril dihydrate.
- The other components (excipients) are: Calcium hydrogen phosphate, magnesium stearate, pregelatinized cornstarch, mannitol and cornstarch.
Appearance of the product and contents of the packaging
Lisinopril Teva 20mg are white, oval-shaped tablets, marked “LSN20”on one side and with a groove on the other side. Each package contains 28 tablets.
The medication is presented in blisters of 14, 28, 30, 50, 100 and 500 tablets and in a clinical pack of 50 and 100 tablets.
Holder of the marketing authorization and responsible for themanufacturing
Holder of the marketing authorization:
Teva Pharma, S.L.U.
C/ Anabel Segura 11, Edificio Albatros B, 1st floor.
28108 Alcobendas. Madrid.
Responsible for the manufacturing:
Pharmachemie BV
Swensweg 5, P.O.Box 552, 2003 RN Haarlem
Holland
TEVA Pharmaceutical WorksPrivate Limited Company
Pallagi str. 13
H-4042 Debrecen
Hungary
This medication is authorized in the Member States of the European Economic Area with the following names:
Germany: Lisinopril-TEVA® 20 mg Tablets
Belgium: Lisinophar 20 mg Tablets
Spain: Lisinopril Teva 20 mg tablets EFG
Last review date of this leaflet: April 2022
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http: //www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.